Search This Blog

Monday, March 9, 2015

Bioplastic



From Wikipedia, the free encyclopedia

Bioplastics are plastics derived from renewable biomass sources, such as vegetable fats and oils, corn starch, pea starch[1] or microbiota.[2] Bioplastic can be made from agricultural byproducts and also from used plastic bottles and other containers using microorganisms. Common plastics, such as fossil-fuel plastics (also called petrobased polymers), are derived from petroleum. Production of such plastics tends to require more fossil fuels and to produce more greenhouse gases than the production of biobased polymers (bioplastics). Some, but not all, bioplastics are designed to biodegrade. Biodegradable bioplastics can break down in either anaerobic or aerobic environments, depending on how they are manufactured. Bioplastics can be composed of starches, cellulose, biopolymers, and a variety of other materials.
IUPAC definition
Biobased polymer derived from the biomass or issued from monomers derived
from the biomass and which, at some stage in its processing into finished
products, can be shaped by flow.
Note 1: Bioplastic is generally used as the opposite of polymer derived from
fossil resources.
Note 2: Bioplastic is misleading because it suggests that any polymer derived
from the biomass is environmentally friendly.
Note 3: The use of the term "bioplastic" is discouraged. Use the expression
"biobased polymer".
Note 4: A biobased polymer similar to a petrobased one does not imply any
superiority with respect to the environment unless the comparison of respective
life cycle assessments is favourable.[3]

Biodegradable plastic utensils

Packaging peanuts made from bioplastics (thermoplastic starch)

Plastics packaging made from bioplastics and other biodegradable plastics

Applications


Flower wrapping made of PLA-blend bio-flex

Bioplastics are used for disposable items, such as packaging, crockery, cutlery, pots, bowls, and straws.[4] They are also often used for bags, trays, fruit and vegetable containers and blister foils, egg cartons, meat packaging, vegetables, and bottling for soft drinks and dairy products.

These plastics are also used in non-disposable applications including mobile phone casings, carpet fibres, insulation car interiors, fuel lines, and plastic piping. New electroactive bioplastics are being developed that can be used to carry electrical current.[5] In these areas, the goal is not biodegradability, but to create items from sustainable resources.

Medical implants made of PLA, which dissolve in the body, can save patients a second operation. Compostable mulch films can also be produced from starch polymers and used in agriculture. These films do not have to be collected after use on farm fields.[6]

Bioplastic types

Starch-based plastics

Thermoplastic starch currently represents the most widely used bioplastic, constituting about 50 percent of the bioplastics market[citation needed]. Simple starch bioplastic can be made at home.[7] Pure starch is able to absorb humidity, and is thus a suitable material for the production of drug capsules by the pharmaceutical sector. Flexibiliser and plasticiser such as sorbitol and glycerine can also be added so the starch can also be processed thermo-plastically. The characteristics of the resulting bioplastic (also called "thermo-plastical starch") can be tailored to specific needs by adjusting the amounts of these additives.

Starch-based bioplastics are often blended with biodegradable polyesters to produce starch/polycaprolactone[8] or starch/Ecoflex[9] (polybutylene adipate-co-terephthalate produced by BASF[10]). blends. These blends are used for industrial applications and are also compostable. Other producers, such as Roquette, have developed other starch/polyolefin blends. These blends are not biodegradable, but have a lower carbon footprint than petroleum-based plastics used for the same applications.[11]

Cellulose-based plastics


A packaging blister made from cellulose acetate, a bioplastic

Cellulose bioplastics are mainly the cellulose esters, (including cellulose acetate and nitrocellulose) and their derivatives, including celluloid.

Some aliphatic polyesters

The aliphatic biopolyesters are mainly polyhydroxyalkanoates (PHAs) like the poly-3-hydroxybutyrate (PHB), polyhydroxyvalerate (PHV) and polyhydroxyhexanoate (PHH).

Polylactic acid (PLA)


Mulch film made of polylactic acid (PLA)-blend bio-flex

Polylactic acid (PLA) is a transparent plastic produced from corn[12] or dextrose. Its characteristics are similar to conventional petrochemical-based mass plastics (like PET, PS or PE), and it can be processed using standard equipment that already exists for the production of some conventional plastics. PLA and PLA blends generally come in the form of granulates with various properties, and are used in the plastic processing industry for the production of films, fibers, plastic containers, cups and bottles.

Poly-3-hydroxybutyrate (PHB)

The biopolymer poly-3-hydroxybutyrate (PHB) is a polyester produced by certain bacteria processing glucose, corn starch[13] or wastewater.[14] Its characteristics are similar to those of the petroplastic polypropylene. PHB production is increasing. The South American sugar industry, for example, has decided to expand PHB production to an industrial scale. PHB is distinguished primarily by its physical characteristics. It can be processed into a transparent film with a melting point higher than 130 degrees Celsius, and is biodegradable without residue.

Polyhydroxyalkanoates (PHA)

Polyhydroxyalkanoates are linear polyesters produced in nature by bacterial fermentation of sugar or lipids. They are produced by the bacteria to store carbon and energy. In industrial production, the polyester is extracted and purified from the bacteria by optimizing the conditions for the fermentation of sugar. More than 150 different monomers can be combined within this family to give materials with extremely different properties. PHA is more ductile and less elastic than other plastics, and it is also biodegradable. These plastics are being widely used in the medical industry.

Polyamide 11 (PA 11)

PA 11 is a biopolymer derived from natural oil. It is also known under the tradename Rilsan B, commercialized by Arkema. PA 11 belongs to the technical polymers family and is not biodegradable. Its properties are similar to those of PA 12, although emissions of greenhouse gases and consumption of nonrenewable resources are reduced during its production. Its thermal resistance is also superior to that of PA 12. It is used in high-performance applications like automotive fuel lines, pneumatic airbrake tubing, electrical cable antitermite sheathing, flexible oil and gas pipes, control fluid umbilicals, sports shoes, electronic device components, and catheters.

A similar plastic is Polyamide 410 (PA 410), derived 70% from castor oil, under the trade name EcoPaXX, commercialized by DSM.[15] PA 410 is a high-performance polyamide that combines the benefits of a high melting point (approx. 250 °C), low moisture absorption and excellent resistance to various chemical substances.

Bio-derived polyethylene

The basic building block (monomer) of polyethylene is ethylene. Ethylene is chemically similar to, and can be derived from ethanol, which can be produced by fermentation of agricultural feedstocks such as sugar cane or corn. Bio-derived polyethylene is chemically and physically identical to traditional polyethylene – it does not biodegrade but can be recycled. Bio derivation of polyethylene can also reduce greenhouse gas emissions considerably. Brazilian chemicals group Braskem claims that using its method of producing polyethylene from sugar cane ethanol captures (removes from the environment) 2.5 tonnes of carbon dioxide per tonne of polyethylene produced, while the traditional petrochemical production method results in emissions of close to 3.5 tonnes.
Braskem plans to introduce commercial quantities of its first bio-derived high density polyethylene, to be used in a packaging such as bottles and tubs, in 2010, and has developed a technology to produce bio-derived butene, which is required to make the linear low density polyethylene types used in film production.[16]

Genetically modified bioplastics

Genetic modification (GM) is also a challenge for the bioplastics industry. None of the currently available bioplastics – which can be considered first generation products – require the use of GM crops, although GM corn is the standard feedstock.

Looking further ahead, some of the second generation bioplastics manufacturing technologies under development employ the "plant factory" model, using genetically modified crops or genetically modified bacteria to optimise efficiency.

Environmental impact


Confectionery packaging made of PLA-blend bio-flex

Bottles made from cellulose acetate biograde

Drinking straws made of PLA-blend bio-flex

Jar made of PLA-blend bio-flex, a bioplastic

The environmental impact of bioplastics is often debated, as there are many different metrics for "greenness" (e.g., water use, energy use, deforestation, biodegradation, etc.) and tradeoffs often exist.[17] The debate is also complicated by the fact that many different types of bioplastics exist, each with different environmental strengths and weaknesses, so not all bioplastics can be treated as equal.

The production and use of bioplastics is sometimes regarded as a more sustainable activity when compared with plastic production from petroleum (petroplastic), because it requires less fossil fuel for its production and also introduces fewer, net-new greenhouse emissions if it biodegrades. The use of bioplastics can also result in less hazardous waste than oil-derived plastics, which remain solid for hundreds of years.

Petroleum is often still used as a source of materials and energy in the production of bioplastic. Petroleum is required to power farm machinery, to irrigate crops, to produce fertilisers and pesticides, to transport crops and crop products to processing plants, to process raw materials, and ultimately to produce the bioplastic. However, it is possible to produce bioplastic using renewable energy sources and avoid the use of petroleum.

Italian bioplastic manufacturer Novamont[18] states in its own environmental audit that producing one kilogram of its starch-based product uses 500 g of petroleum and consumes almost 80% of the energy required to produce a traditional polyethylene polymer. Environmental data from NatureWorks, the only commercial manufacturer of PLA (polylactic acid) bioplastic, says that making its plastic material delivers a fossil fuel saving of between 25 and 68 per cent compared with polyethylene, in part due to its purchasing of renewable energy certificates for its manufacturing plant.

A detailed study examining the process of manufacturing a number of common packaging items from traditional plastics and polylactic acid carried out by Franklin Associates and published by the Athena Institute shows that using bioplastic has a lower environmental impact for some products, and a higher environmental impact for others.[19] This study, however, does not factor in the end-of-life environmental impact of these products, including possible methane emissions from landfills due to biodegradable plastics.

While production of most bioplastics results in reduced carbon dioxide emissions compared to traditional alternatives, there is concern that the creation of a global bioeconomy required to produce bioplastic in large quantities could contribute to an accelerated rate of deforestation and soil erosion, and could adversely affect water supplies. Careful management of a global bioeconomy would be required.

Other studies showed that bioplastics result in a 42% reduction in carbon footprint.[20]

On October 21, 2010, a group of scientists reported that corn-based plastic ranked higher in environmental defects than the main products it replaces, such as HDPE, LDPE and PP. In the study, the production of corn-based plastics created more acidification, carcinogens, ecotoxicity, eutrophication, ozone depletion, respiratory effects and smog than the synthetic-based plastics they replaced.[21] However the study also concluded that biopolymers trumped the other plastics for biodegradability, low toxicity, and use of renewable resources.

The American Carbon Registry has also released reports of nitrous oxide caused from corn growing which is 310 times more potent than CO2. Pesticides are also used in growing corn-based plastic.[22]

Bioplastics and biodegradation

Packaging air pillow made of PLA-blend bio-flex

The terminology used in the bioplastics sector is sometimes misleading. Most in the industry use the term bioplastic to mean a plastic produced from a biological source. All (bio- and petroleum-based) plastics are technically biodegradable, meaning they can be degraded by microbes under suitable conditions. However, many degrade so slowly that they are considered non-biodegradable. Some petrochemical-based plastics are considered biodegradable, and may be used as an additive to improve the performance of commercial bioplastics.[23] Non-biodegradable bioplastics are referred to as durable. The biodegradability of bioplastics depends on temperature, polymer stability, and available oxygen content. The European standard EN13432, published by the International Organization for Standardization, defines how quickly and to what extent a plastic must be degraded under the tightly controlled and aggressive conditions (at or above 140 °F) of an industrial composting unit for it to be considered biodegradable. This standard is recognized in many countries, including all of Europe, Japan and the US. However, it applies only to industrial composting units and does not set out a standard for home composting. Most bioplastics (e.g. PH) only biodegrade quickly in industrial composting units. These materials do not biodegrade quickly in ordinary compost piles or in the soil/water. Starch-based bioplastics are an exception, and will biodegrade in normal composting conditions.[24]

The term "biodegradable plastic" has also been used by producers of specially modified petrochemical-based plastics that appear to biodegrade.[25] Biodegradable plastic bag manufacturers that have misrepresented their product's biodegradability may now face legal action in the US state of California for the misleading use of the terms biodegradable or compostable.[26] Traditional plastics such as polyethylene are degraded by ultra-violet (UV) light and oxygen. To prevent this, process manufacturers add stabilising chemicals. However with the addition of a degradation initiator to the plastic, it is possible to achieve a controlled UV/oxidation disintegration process. This type of plastic may be referred to as degradable plastic or oxy-degradable plastic or photodegradable plastic because the process is not initiated by microbial action. While some degradable plastics manufacturers argue that degraded plastic residue will be attacked by microbes, these degradable materials do not meet the requirements of the EN13432 commercial composting standard. The bioplastics industry has widely criticized oxo-biodegradable plastics, which the industry association says do not meet its requirements. Oxo-biodegradable plastics – known as "oxos" – are conventional petroleum-based products with some additives that initiate degradation. The ASTM standard for oxo-biodegradables is called the Standard Guide for Exposing and Testing Plastics that Degrade in the Environment by a Combination of Oxidation and Biodegradation (ASTM 6954).[27] Both EN 13432 and ASTM 6400 are specifically designed for PLA and Starch based products and should not be used as a guide for oxos.

Market


Tea bags made of polylactide (PLA), (peppermint tea)

Prism pencil sharpener made from cellulose acetate biograde

Because of the fragmentation in the market and ambiguous definitions it is difficult to describe the total market size for bioplastics, but estimates put global production capacity at 327,000 tonnes.[28] In contrast, global consumption of all flexible packaging is estimated at around 12.3 million tonnes.[29]

COPA (Committee of Agricultural Organisation in the European Union) and COGEGA (General Committee for the Agricultural Cooperation in the European Union) have made an assessment of the potential of bioplastics in different sectors of the European economy:
Catering products: 450,000 tonnes per year
Organic waste bags: 100,000 tonnes per year
Biodegradable mulch foils: 130,000 tonnes per year
Biodegradable foils for diapers 80,000 tonnes per year
Diapers, 100% biodegradable: 240,000 tonnes per year
Foil packaging: 400,000 tonnes per year
Vegetable packaging: 400,000 tonnes per year
Tyre components: 200,000 tonnes per year
Total: 2,000,000 tonnes per year
In the years 2000 to 2008, worldwide consumption of biodegradable plastics based on starch, sugar, and cellulose – so far the three most important raw materials – has increased by 600%.[30] The NNFCC predicted global annual capacity would grow more than six-fold to 2.1 million tonnes by 2013.[28] BCC Research forecasts the global market for biodegradable polymers to grow at a compound average growth rate of more than 17 percent through 2012. Even so, bioplastics will encompass a small niche of the overall plastic market, which is forecast to reach 500 billion pounds (220 million tonnes) globally by 2010.[31] Ceresana forecasts the world market for bioplastics to reach 5.8 billion US dollars in 2021 - i.e. three times more than in 2014.[32]

Cost

At one time bioplastics were too expensive for consideration as a replacement for petroleum-based plastics. The lower temperatures needed to process bioplastics and the more stable supply of biomass combined with the increasing cost of crude oil make bioplastics' prices [33] more competitive with regular plastics.

Research and development

Bioplastics Development Center - University of Massachusetts Lowell

A pen made with bioplastics (Polylactide, PLA)
  • In the early 1950s, amylomaize (>50% amylose content corn) was successfully bred and commercial bioplastics applications started to be explored.
  • In 2004, NEC developed a flame retardant plastic, polylactic acid, without using toxic chemicals such as halogens and phosphorus compounds.[34]
  • In 2005, Fujitsu became one of the first technology companies to make personal computer cases from bioplastics, which are featured in their FMV-BIBLO NB80K line. Later, the French company Ashelvea (also listed on EU Energy Star registered partners), launched its fully recyclable PC with biodegradable plastic case "Evolutis", reported in "People Inspiring Philips", a series of 3 mini-documentaries to inspire Philips employees with some examples from the civil society.[35][36]
  • In 2007 Braskem of Brazil announced it had developed a route to manufacture high density polyethylene (HDPE) using ethylene derived from sugar cane.
  • In 2008, a University of Warwick team created a soap-free emulsion polymerization process which makes colloid particles of polymer dispersed in water, and in a one step process adds nanometre sized silica-based particles to the mix. The newly developed technology might be most applicable to multi-layered biodegradable packaging, which could gain more robustness and water barrier characteristics through the addition of a nano-particle coating.[37]

Testing procedures


A bioplastic shampoo bottle made of PLA-blend bio-flex

Industrial compostability – EN 13432, ASTM D6400

The EN 13432 industrial standard is arguably the most international in scope. This standard must be met in order to claim that a plastic product is compostable in the European marketplace. In summary, it requires biodegradation of 90% of the materials in a lab within 90 days. The ASTM 6400 standard is the regulatory framework for the United States and sets a less stringent threshold of 60% biodegradation within 180 days for non-homopolymers, and 90% biodegradation of homopolymers within industrial composting conditions (temperatures at or above 140F). Municipal compost facilities do not see above 130F.[citation needed]

Many starch-based plastics, PLA-based plastics and certain aliphatic-aromatic co-polyester compounds, such as succinates and adipates, have obtained these certificates. Additive-based bioplastics sold as photodegradable or Oxo Biodegradable do not comply with these standards in their current form.

Compostability – ASTM D6002

The ASTM D 6002 method for determining the compostability of a plastic defined the word compostable as follows:
that which is capable of undergoing biological decomposition in a compost site such that the material is not visually distinguishable and breaks down into carbon dioxide, water, inorganic compounds and biomass at a rate consistent with known compostable materials.[38]
This definition drew much criticism for the fact that, contrary to the way the word is traditionally defined, it completely divorces the process of "composting" from the necessity of it leading to humus/compost as the end product. Indeed, the only criteria this standard does describe is that a compostable plastic must look to be going away as fast as something else we have already established to be compostable under the traditional definition.

Withdrawal of ASTM D 6002

In January 2011, the ASTM withdrew standard ASTM D 6002, which had provided plastic manufacturers with the legal credibility to label a plastic as compostable. Its description is as follows:
This guide covered suggested criteria, procedures, and a general approach to establish the compostability of environmentally degradable plastics.[39]
The ASTM has yet to replace this standard.

Biobased – ASTM D6866

The ASTM D6866 method has been developed to certify the biologically derived content of bioplastics. Cosmic rays colliding with the atmosphere mean that some of the carbon is the radioactive isotope carbon-14. CO2 from the atmosphere is used by plants in photosynthesis, so new plant material will contain both carbon-14 and carbon-12. Under the right conditions, and over geological timescales, the remains of living organisms can be transformed into fossil fuels. After ~100,000 years all the carbon-14 present in the original organic material will have undergone radioactive decay leaving only carbon-12. A product made from biomass will have a relatively high level of carbon-14, while a product made from petrochemicals will have no carbon-14. The percentage of renewable carbon in a material (solid or liquid) can be measured with an accelerator mass spectrometer.[40][41]

There is an important difference between biodegradability and biobased content. A bioplastic such as high density polyethylene (HDPE)[42] can be 100% biobased (i.e. contain 100% renewable carbon), yet be non-biodegradable. These bioplastics such as HDPE nonetheless play an important role in greenhouse gas abatement, particularly when they are combusted for energy production. The biobased component of these bioplastics is considered carbon-neutral since their origin is from biomass.

Anaerobic biodegradability – ASTM D5511-02 and ASTM D5526

The ASTM D5511-12 and ASTM D5526-12 are testing methods that comply with international standards such as the ISO DIS 15985 for the biodegradability of plastic.

Legal implications

In 2012 the Attorney General of Vermont sued a BPI certified product claiming "compostable plastic" for false claims, these claims were made under the pretense that industrial compost facilities existed by BPI, through further examination these industrial compost facilities were nowhere to be found.[43]

Genetically modified organism



From Wikipedia, the free encyclopedia


GloFish, the first genetically modified animal to be sold as a pet

A genetically modified organism (GMO) is any organism whose genetic material has been altered using genetic engineering techniques. GMOs are the source of genetically modified foods and are also widely used in scientific research and to produce goods other than food. The term GMO is very close to the technical legal term, 'living modified organism', defined in the Cartagena Protocol on Biosafety, which regulates international trade in living GMOs (specifically, "any living organism that possesses a novel combination of genetic material obtained through the use of modern biotechnology").

This article focuses on what organisms have been genetically engineered, and for what purposes. The article on genetic engineering focuses on the history and methods of genetic engineering, and on applications of genetic engineering and of GMOs. Both articles cover much of the same ground but with different organizations (sorted by organism in this article; sorted by application in the other). There are separate articles on genetically modified crops, genetically modified food, regulation of the release of genetic modified organisms, and controversies.

Production

Genetic modification involves the mutation, insertion, or deletion of genes. Inserted genes usually come from a different species in a form of horizontal gene-transfer. In nature this can occur when exogenous DNA penetrates the cell membrane for any reason. To do this artificially may require:
  • attaching the genes to a virus
  • physically inserting the extra DNA into the nucleus of the intended host with a very small syringe
  • with the use of electroporation (that is, introducing DNA from one organism into the cell of another by use of an electric pulse)
  • with very small particles fired from a gene gun.[1][2][3]
Other methods exploit natural forms of gene transfer, such as the ability of Agrobacterium to transfer genetic material to plants,[4] or the ability of lentiviruses to transfer genes to animal cells.[5]

History

Humans have domesticated plants and animals since around 12,000 BCE, using selective breeding or artificial selection (as contrasted with natural selection).[6]:25 The process of selective breeding, in which organisms with desired traits (and thus with the desired genes) are used to breed the next generation and organisms lacking the trait are not bred, is the oldest form of genetic modification by humans.[7]:1[8]:1 When nucleic acid sequences are combined in a laboratory, the resulting DNA is called recombinant DNA.[9] Recombinant DNA may contain oligonucleotides from the same or similar species, in which case it is called "cisgenic", or may contain oligonucleotides from different organisms that could not naturally interbreed, in which case it is called "transgenic".[10] Recombinant DNA may also contain synthetic sequences.
The first recombinant DNA molecules were produced by Paul Berg in 1972.[11][12]Genetic engineering, the direct manipulation of genes using biotechnology, was first accomplished by Herbert Boyer and Stanley Cohen in 1973.[13] Whereas selective breeding depends on naturally occurring genetic variation within a population or species, genetic engineering can involve the intentional introduction of genes from different species. Advances have allowed scientists to manipulate, remove, and add genes to a variety of different organisms to induce a range of different traits. From 1976 the technology became commercialized, with companies producing and selling genetically modified foods and medicines.

Uses

GMOs are used in biological and medical research, production of pharmaceutical drugs, experimental medicine (e.g. gene therapy), and agriculture (e.g. golden rice, resistance to herbicides). The term "genetically modified organism" does not always imply, but can include, targeted insertions of genes from one species into another. For example, a gene from a jellyfish, encoding a fluorescent protein called GFP, or green fluorescent protein, can be physically linked and thus co-expressed with mammalian genes to identify the location of the protein encoded by the GFP-tagged gene in the mammalian cell. Such methods are useful tools for biologists in many areas of research, including those who study the mechanisms of human and other diseases or fundamental biological processes in eukaryotic or prokaryotic cells.

Microbes

Bacteria were the first organisms to be modified in the laboratory, due to their simple genetics.[14]
They continue to be important model organisms for experiments in genetic engineering. In the field of synthetic biology, they have been used to test various synthetic approaches, from synthesizing genomes to creating novel nucleotides.[15][16][17]

These organisms are now used for several purposes, and are particularly important in producing large amounts of pure human proteins for use in medicine.[18]

Genetically modified bacteria are used to produce the protein insulin to treat diabetes.[19] Similar bacteria have been used to produce biofuels,[20] clotting factors to treat haemophilia,[21] and human growth hormone to treat various forms of dwarfism.[22][23]

In addition, various genetically engineered micro-organisms are routinely used as sources of enzymes for the manufacture of a variety of processed foods. These include alpha-amylase from bacteria, which converts starch to simple sugars, chymosin from bacteria or fungi, which clots milk protein for cheese making, and pectinesterase from fungi, which improves fruit juice clarity.[24]

Plants

Transgenic plants


Kenyans examining insect-resistant transgenic Bt corn

Transgenic plants have been engineered for scientific research, to create new colours in plants, and to create different crops.

In research, plants are engineered to help discover the functions of certain genes. One way to do this is to knock out the gene of interest and see what phenotype develops. Another strategy is to attach the gene to a strong promoter and see what happens when it is over expressed. A common technique used to find out where the gene is expressed is to attach it to GUS or a similar reporter gene that allows visualisation of the location.[25]'

Suntory "blue" rose

After thirteen years of collaborative research, an Australian company – Florigene, and a Japanese company – Suntory, created a blue rose (actually lavender or mauve) in 2004.[26] The genetic engineering involved three alterations – adding two genes, and interfering with another. One of the added genes was for the blue plant pigment delphinidin cloned from the pansy.[27] The researchers then used RNA interference (RNAi) technology to depress all color production by endogenous genes by blocking a crucial protein in color production, called dihydroflavonol 4-reductase) (DFR), and adding a variant of that protein that would not be blocked by the RNAi but that would allow the delphinidin to work.[27] The roses are sold in Japan, the United States, and Canada.[28][29] Florigene has also created and sells lavender-colored carnations that are genetically engineered in a similar way.[27]

Simple plants and plant cells have been genetically engineered for production of biopharmaceuticals in bioreactors as opposed to cultivating plants in open fields. Work has been done with duckweed Lemna minor,[30] the algae Chlamydomonas reinhardtii[31] and the moss Physcomitrella patens.[32][33] An Israeli company, Protalix, has developed a method to produce therapeutics in cultured transgenic carrot and tobacco cells.[34] Protalix and its partner, Pfizer, received FDA approval to market its drug Elelyso, a treatment for Gaucher's disease, in 2012.[35]
Genetically modified crops
In agriculture, currently marketed genetically engineered crops have traits such as resistance to pests, resistance to herbicides, increased nutritional value, or production of valuable goods such as drugs (pharming). Products under development include crops that are able to thrive in environmental conditions outside the species' native range or in changed conditions in their range (e.g. drought or salt resistance). Products that existed and have been withdrawn include those with extended product shelf life, such as the Flavr-savr tomato.
Since the first commercial cultivation of genetically modified plants in 1996, they have been modified to be tolerant to the herbicides glufosinate and glyphosate, to be resistant to virus damage (as in Ringspot virus-resistant GM papaya grown in Hawaii), and to produce the Bt toxin, an insecticide that is documented as non-toxic to mammals.[36][37] Plants, including algae, jatropha, maize, and poplars,[38] have been genetically modified for use in producing fuel, known as biofuel.

Second- and third-generation GM crops are on the market and under development with improved nutrition profiles and increased yields or ability to thrive in difficult environments.[39] GM oilseed crops on the market today offer improved oil profiles for processing or healthier edible oils.[40] Other examples include:
For discussions of issues about GM crops and GM food, see the Controversies section below and the article on genetically modified food controversies.

Cisgenic plants

Cisgenesis, sometimes also called intragenesis, is a product designation for a category of genetically engineered plants. A variety of classification schemes have been proposed[46] that order genetically modified organisms based on the nature of introduced genotypical changes rather than the process of genetic engineering.

While some genetically modified plants are developed by the introduction of a gene originating from distant, sexually incompatible species into the host genome, cisgenic plants contain genes that have been isolated either directly from the host species or from sexually compatible species. The new genes are introduced using recombinant DNA methods and gene transfer. Some scientists hope that the approval process of cisgenic plants might be simpler than that of proper transgenics,[47] but it remains to be seen.[48]

Mammals



Some chimeras, like the blotched mouse shown, are created through genetic modification techniques like gene targeting.

Genetically modified mammals are an important category of genetically modified organisms.[49] Ralph L. Brinster and Richard Palmiter developed the techniques responsible for transgenic mice, rats, rabbits, sheep, and pigs in the early 1980s, and established many of the first transgenic models of human disease, including the first carcinoma caused by a transgene. The process of genetically engineering animals is a slow, tedious, and expensive process. However, new technologies are making genetic modifications easier and more precise.[50]

The first transgenic (genetically modified) animal was produced by injecting DNA into mouse embryos then implanting the embryos in female mice.[51]

Genetically modified animals currently being developed can be placed into six different broad classes based on the intended purpose of the genetic modification:
  1. to research human diseases (for example, to develop animal models for these diseases);
  2. to produce industrial or consumer products (fibres for multiple uses);
  3. to produce products intended for human therapeutic use (pharmaceutical products or tissue for implantation);
  4. to enrich or enhance the animals' interactions with humans (hypo-allergenic pets);
  5. to enhance production or food quality traits (faster growing fish, pigs that digest food more efficiently);
  6. to improve animal health (disease resistance)[52]

Research use

Transgenic animals are used as experimental models to perform phenotypic and for testing in biomedical research.[53]

Genetically modified (genetically engineered) animals are becoming more vital to the discovery and development of cures and treatments for many serious diseases. By altering the DNA or transferring DNA to an animal, we can develop certain proteins that may be used in medical treatment. Stable expressions of human proteins have been developed in many animals, including sheep, pigs, and rats. Human-alpha-1-antitrypsin,[54] which has been tested in sheep and is used in treating humans with this deficiency and transgenic pigs with human-histo-compatibility have been studied in the hopes that the organs will be suitable for transplant with less chances of rejection.

Scientists have genetically engineered several organisms, including some mammals, to include green fluorescent protein (GFP) for medical research purposes (Chalfie, Shimoura, and Tsien were awarded the Nobel prize in 2008 for GFP[55]). For example fluorescent pigs have been bred in order to study human organ transplants, regenerating ocular photoreceptor cells, and other topics.[56] In 2011 a Japanese-American Team created green-fluorescent cats in order to find therapies for HIV/AIDS and other diseases[57] as Feline immunodeficiency virus (FIV) is related to HIV.[58]

In 2009, scientists in Japan announced that they had successfully transferred a gene into a primate species (marmosets) and produced a stable line of breeding transgenic primates for the first time.[59][60] Their first research target for these marmosets was Parkinson's disease, but they were also considering Amyotrophic lateral sclerosis and Huntington's disease.[61]

Producing human therapeutics

Within the field known as pharming, intensive research has been conducted to develop transgenic animals that produce biotherapeutics.[62] On 6 February 2009, the U.S. Food and Drug Administration approved the first human biological drug produced from such an animal, a goat. The drug, ATryn, is an anticoagulant which reduces the probability of blood clots during surgery or childbirth. It is extracted from the goat's milk.[63]

Production or food quality traits

Enviropig was a genetically enhanced line of Yorkshire pigs in Canada created with the capability of digesting plant phosphorus more efficiently than conventional Yorkshire pigs. The project ended in 2012.[64][65] These pigs produced the enzyme phytase, which breaks down the indigestible phosphorus, in their saliva. The enzyme was introduced into the pig chromosome by pronuclear microinjection. With this enzyme, the animal is able to digest cereal grain phosphorus.[64][66] The use of these pigs would reduce the potential of water pollution since they excrete from 30 to 70.7% less phosphorus in manure depending upon the age and diet.[64][66] The lower concentrations of phosphorus in surface runoff reduces algal growth, because phosphorus is the limiting nutrient for algae.[64] Because algae consume large amounts of oxygen, it can result in dead zones for fish.

In 2011, Chinese scientists generated dairy cows genetically engineered with genes from human beings in order to produce milk that would be the same as human breast milk.[67] This could potentially benefit mothers who cannot produce breast milk but want their children to have breast milk rather than formula. Aside from milk production, the researchers claim these transgenic cows to be identical to regular cows.[68] Two months later scientists from Argentina presented Rosita, a transgenic cow incorporating two human genes, to produce milk with similar properties as human breast milk.[69] In 2012, researchers from New Zealand also developed a genetically engineered cow that produced allergy-free milk.[70]

In 2006, a pig was engineered to produce omega-3 fatty acids through the expression of a roundworm gene.[71]

Goats have been genetically engineered to produce milk with strong spiderweb-like silk proteins in their milk.[72]

Genetically modified fish have been developed with promoters driving an over-production of growth hormone for use in the aquaculture industry to increase the speed of development and potentially reduce fishing pressure on wild stocks. AquaBounty, a biotechnology company working on bringing a GM salmon to market, claims that their GM AquAdvantage salmon can mature in half the time it takes non-GM salmon and achieves twice the size.[73] AquaBounty has applied for regulatory approval to market their GM salmon in the US. As of May 2012 the application was still pending.[74] On 25 November 2013 Canada approved commercial scale production and export of GM Salmon eggs but they are not approved for human consumption in Canada.[75]

Human gene therapy

Gene therapy,[76] uses genetically modified viruses to deliver genes that can cure disease in humans. Although gene therapy is still relatively new, it has had some successes. It has been used to treat genetic disorders such as severe combined immunodeficiency,[77] and Leber's congenital amaurosis.[78] Treatments are also being developed for a range of other currently incurable diseases, such as cystic fibrosis,[79] sickle cell anemia,[80] Parkinson's disease,[81][82] cancer,[83][84][85] diabetes,[86] heart disease[87] and muscular dystrophy.[88] Current gene therapy technology only targets the non-reproductive cells meaning that any changes introduced by the treatment can not be transmitted to the next generation. Gene therapy targeting the reproductive cells—so-called "Germ line Gene Therapy"—is very controversial and is unlikely to be developed in the near future.

Insects

Fruit flies

In biological research, transgenic fruit flies (Drosophila melanogaster) are model organisms used to study the effects of genetic changes on development.[89] Fruit flies are often preferred over other animals due to their short life cycle, low maintenance requirements, and relatively simple genome compared to many vertebrates.

Mosquitoes

In 2010, scientists created "malaria-resistant mosquitoes" in the laboratory.[90][91][92] The World Health Organization estimated that malaria killed almost one million people in 2008.[93] Genetically modified male mosquitoes containing a lethal gene have been developed in order to combat the spread of dengue fever.[94] Aedes aegypti mosquitoes, the single most important carrier of dengue fever, were reduced by 80% in a 2010 trial of these GM mosquitoes in the Cayman Islands.[95][96]
Between 50 and 100 million people are affected by dengue fever every year and 40,000 people die from it.[97]

Bollworms

A strain of Pectinophora gossypiella (Pink bollworm) has been genetically engineered to express a red fluorescent protein. This allows researchers to monitor bollworms that have been sterilized by radiation and released in order to reduce bollworm infestation. The strain has been field tested for over three years and has been approved for release.[97][98][99]

Aquatic life

Cnidarians

Cnidarians such as Hydra and the sea anemone Nematostella vectensis have become attractive model organisms to study the evolution of immunity and certain developmental processes. An important technical breakthrough was the development of procedures for generation of stably transgenic hydras and sea anemones by embryo microinjection.[100]

Fish

GM fish are used for scientific research and as pets, and are being considered for use as food and as aquatic pollution sensors.

Genetically engineered fish are widely used in basic research in genetics and development. Two species of fish, zebrafish and medaka, are most commonly modified because they have optically clear chorions (shells), rapidly develop, and the 1-cell embryo is easy to see and microinject with transgenic DNA.[101]

The GloFish is a patented[102] brand of genetically modified (GM) fluorescent zebrafish with bright red, green, and orange fluorescent color. Although not originally developed for the ornamental fish trade, it became the first genetically modified animal to become publicly available as a pet when it was introduced for sale in 2003.[103] They were quickly banned for sale in California.[104]

Genetically modified fish have been developed with promoters driving an over-production of "all fish" growth hormone for use in the aquaculture industry to increase the speed of development and potentially reduce fishing pressure on wild stocks. This has resulted in dramatic growth enhancement in several species, including salmon,[105] trout[106] and tilapia.[107] AquaBounty, a biotechnology company working on bringing a GM salmon to market, claims that their GM AquAdvantage salmon can mature in half the time it takes non-GM salmon and achieves twice the size.[73] AquaBounty has applied for regulatory approval to market their GM salmon in the US. As of December 2012 the application was still pending.[74][108]

Several academic groups have been developing GM zebrafish to detect aquatic pollution. The lab that originated the GloFish discussed above originally developed them to change color in the presence of pollutants, to be used as environmental sensors.[109][110] A lab at University of Cincinnati has been developing GM zebrafish for the same purpose,[111][112] as has a lab at Tulane University.[113]

Regulation

The regulation of genetic engineering concerns the approaches taken by governments to assess and manage the risks associated with the use of genetic engineering technology and the development and release of genetically modified organisms (GMO), including genetically modified crops and genetically modified fish. There are differences in the regulation of GMOs between countries, with some of the most marked differences occurring between the USA and Europe.[114] Regulation varies in a given country depending on the intended use of the products of the genetic engineering. For example, a crop not intended for food use is generally not reviewed by authorities responsible for food safety.[115] The European Union differentiates between approval for cultivation within the EU and approval for import and processing. While only a few GMOs have been approved for cultivation in the EU a number of GMOs have been approved for import and processing.[116] The cultivation of GMOs has triggered a debate about coexistence of GM and nonGM crops. Depending on the coexistence regulations, incentives for cultivation of GM crops differ.[117]

Controversy

There is controversy over GMOs, especially with regard to their use in producing food. The dispute involves consumers, biotechnology companies, governmental regulators, non-governmental organizations, and scientists. The key areas of controversy related to GMO food are whether GM food should be labeled, the role of government regulators, the effect of GM crops on health and the environment, the effect on pesticide resistance, the impact of GM crops for farmers, and the role of GM crops in feeding the world population.
There is broad scientific consensus that food on the market derived from GM crops poses no greater risk than conventional food.[118][119][120][121] No reports of ill effects have been proven in the human population from ingesting GM food.[118][122][123][124] Although labeling of GMO products in the marketplace is required in many countries, it is not required in the United States and no distinction between marketed GMO and non-GMO foods is recognized by the US FDA. In a May 2014 article in The Economist it was argued that, while GM foods could potentially help feed 842 million malnourished people globally, laws such as those being considered by Vermont's governor, Peter Shumlin, to require labeling of foods containing genetically modified ingredients, could have the unintended consequence of interrupting the benign process of spreading GM technologies to impoverished countries that suffer with food security problems.[118]

Opponents of genetically modified food such as the advocacy groups Organic Consumers Association, the Union of Concerned Scientists,[125][126][127][128][129] and Greenpeace claim risks have not been adequately identified and managed, and they have questioned the objectivity of regulatory authorities. Some health groups say there are unanswered questions regarding the potential long-term impact on human health from food derived from GMOs, and propose mandatory labeling[130][131] or a moratorium on such products.[132][133][134] Concerns include contamination of the non-genetically modified food supply,[135] effects of GMOs on the environment and nature,[132][134] the rigor of the regulatory process,[133][136] and consolidation of control of the food supply in companies that make and sell GMOs.[132]

Recognition of the originators of GM crops

On 19 June 2013 the leaders of the three research teams that first applied genetic engineering to crops, Robert Fraley of Monsanto; Marc Van Montagu of Ghent University in Belgium and founder of Plant Genetic Systems and Crop Design; and Mary-Dell Chilton of the University of Washington and Washington University in St. Louis and Syngenta, were awarded with the World Food Prize. The prize, of $250,000, is awarded to people who improve the "quality, quantity or availability" of food in the world. The three competing teams first presented their results in January 1983.[137]

Inequality (mathematics)

From Wikipedia, the free encyclopedia https://en.wikipedia.org/wiki/Inequality...